Assessing the residual antibacterial activity of clinical materials disinfected with glutaraldehyde, o-phthalaldehyde, hydrogen peroxide or 2-bromo-2-nitro-1,3-

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

P.-Y. Lévy Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain Y.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy J. Cobo, L. Garcia San Miguel, G. Euba,

Hepatitis B and C virus-related carcinogenesis

Infectious causes of cancer: an evolving educational saga

Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H− human isolates from Finland M. Eklund, M. Bielaszewska, U.-M. Nakari,

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Non-antibiotic strategies for sepsis

Surveillance of Legionnaires’ disease in Austria

Escherichia coli native valve endocarditis

Vector control: a cornerstone in the malaria elimination campaign

Pharmacodynamics of doxycycline

Training for the infectious diseases speciality in Norway

M.N. Al-Hasan, B.D. Lahr, J.E. Eckel-Passow, L.M. Baddour

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

Elements of design: the knowledge on which we build

The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study E. Manea, J. Sojo-Dorado, R.E. Jipa, S.N.

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

B. Sádaba, J.R. Azanza, M.A. Campanero, E. García-Quetglas

Hepatitis B and C virus-related carcinogenesis

Laboratory diagnosis of Clostridium difficile disease

A. Bryskier Clinical Microbiology and Infection

The practice of travel medicine in Europe

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

M. -J. Rodríguez-Hernández, M. E. Jiménez-Mejias, C. Pichardo, L

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Low prevalence of invasive bacterial infection in febrile infants under 3 months of age with enterovirus infection A. Martínez Planas, C. Muñoz Almagro,

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Comparison of different methods for identification of species of the genus Raoultella: report of 11 cases of Raoultella causing bacteraemia and literature.

A.P. Underwood, J. Green Clinical Microbiology and Infection

Antimicrobial drug development – the past, the present, and the future

C. Gagliotti, L. Nobilio, M.L. Moro

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

I. Bitar, A. Piazza Clinical Microbiology and Infection

Clinical Microbiology and Infection

Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria E. Presterl, F. Daxböck, W. Graninger,

First isolation of Conidiobolus sp

M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Are we losing the fight against malaria one more time?

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Assessing the residual antibacterial activity of clinical materials disinfected with glutaraldehyde, o-phthalaldehyde, hydrogen peroxide or 2-bromo-2-nitro-1,3- propanediol by means of a bacterial toxicity assay C. Lerones, A. Mariscal, M. Carnero, A. García-Rodríguez, J. Fernández-Crehuet Clinical Microbiology and Infection Volume 10, Issue 11, Pages 984-989 (November 2004) DOI: 10.1111/j.1469-0691.2004.00967.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Effects of glutaraldehyde, o-phthalaldehyde, 2-bromo-2-nitro-1,3-propanediol and hydrogen peroxide on Escherichia coli β-glucuronidase activity. The symbols represent the individual five replicate tests conducted with each disinfectant. Clinical Microbiology and Infection 2004 10, 984-989DOI: (10.1111/j.1469-0691.2004.00967.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions